LOS ANGELES, California, April 18 -- Paul Hastings, a law firm, issued the following news:

Paul Hastings LLP advised Oppenheimer & Co. and Citizens JMP as joint book running managers in connection with INOVIO Pharmaceutical's underwritten offering.

INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products